down arrow

Traws Pharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68232V8019
  • NASDAQ: ONTX
USD
0.50
0 (0.72%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Applied DNA Sciences, Inc.
Catalyst Biosciences, Inc.
22nd Century Group, Inc.
Elutia, Inc.
Microbot Medical, Inc.
Traws Pharma, Inc.
NeuroBo Pharmaceuticals, Inc.
AquaBounty Technologies, Inc.
Orgenesis, Inc.
BiomX, Inc.
Vascular Biogenics Ltd.

Why is Traws Pharma, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Traws Pharma, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Traws Pharma, Inc.
-73.21%
-0.71
135.72%
S&P 500
15.76%
1.20
13.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
29.56%
EBIT Growth (5y)
-18.65%
EBIT to Interest (avg)
-21.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.66
Sales to Capital Employed (avg)
0.10
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
56.28%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
0
Industry P/E
Price to Book Value
3.09
EV to EBIT
-0.19
EV to EBITDA
-0.19
EV to Capital Employed
-4.08
EV to Sales
2.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
1467.41%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -16.85 MM

NET PROFIT(HY)

Higher at USD -10.22 MM

DEBT-EQUITY RATIO (HY)

Lowest at -296.63 %

-13What is not working for the Company
PRE-TAX PROFIT(Q)

At USD -3.27 MM has Fallen at -208.11%

NET PROFIT(Q)

At USD -3.27 MM has Fallen at -208.11%

RAW MATERIAL COST(Y)

Grown by 101.01% (YoY

CASH AND EQV(HY)

Lowest at USD 8.15 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

Here's what is working for Traws Pharma, Inc.

Operating Cash Flow
Highest at USD -16.85 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -296.63 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Traws Pharma, Inc.

Pre-Tax Profit
At USD -3.27 MM has Fallen at -208.11%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -3.27 MM has Fallen at -208.11%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Cash and Eqv
Lowest at USD 8.15 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 101.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading